National Cancer Centre, Singapore: Carcinoma, Hepatocellular trials

The registry lists 15 Carcinoma, Hepatocellular studies with National Cancer Centre, Singapore as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 6No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Histotripsy for Ablation of Liver Tumours in AsiaRecruitingNCT07428356Not applicable
• Restoring Bile Acid Homeostasis Via Lifestyle Adjustments to Prevent the Development of Liver CancerNot yet recruitingNCT07111130Not applicable
• Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular CarcinomaRecruitingNCT05516628Phase 2
• Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRCRecruitingNCT04912765Phase 2
• Predicting Survival After Surgical Resection for the Entire Spectrum of Anatomically Resectable HCCCompletedNCT06294808
• Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC PatientsActive, not recruitingNCT05377034Phase 2
• Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular CarcinomaActive, not recruitingNCT05148572
• Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)Active, not recruitingNCT04965259
• LiverMultiScan Analysis of MRI Scans in HCCCompletedNCT04451603
• Longitudinal Immune-phenotyping of HCC Following MK-3475Active, not recruitingNCT04224480Phase 1
• Phase II Study of PRL3-ZUMAB in Advanced Solid TumorsCompletedNCT04118114Phase 2
• Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular CarcinomaCompletedNCT03267641
• Hepatocellular Carcinoma Registry in Asia: The INSIGHT RegistryCompletedNCT03233360
• Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular CarcinomaCompletedNCT03033446Phase 2
• AZD6244 and Sorafenib in Advanced Hepatocellular CarcinomaTerminatedNCT01029418Phase 1/2